Bacterial Disease Diagnostics Market Growth, Size, Trends, Share, Challenges and Future Outlook

Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Sep 2023 Report ID: HLCA2357 Pages: 1 - 221 Formats*:     
Category : Healthcare
Bacterial Disease Diagnostics Market Introduction and Overview 

According to SPER Market Research, the Global Bacterial Disease Diagnostics Market is estimated to reach USD XX billion by 2033 with a CAGR of 6.5%.

The report includes an in-depth analysis of the Global Bacterial Disease Diagnostics Market, including market size and trends, product mix, distribution channels, and supplier analysis. Various species of bacteria exist. Some of them are contagious, but the majority of them are good for the body. The term "pathogen" refers to any bacterium that causes an infectious disease. To avoid overusing antibiotics and to target the right therapy, a precise identification of bacterial infection is essential. Since the presence of bacteria and inflammation or systemic dysfunction constitute a bacterial infection, more than one diagnostic technique is typically needed to confirm the diagnosis.

  • F. Hoffmann-La Roche Ltd. formed a partnership with Janssen Biotech Inc. to increase the scope of its target therapy diagnosis portfolio. It boosts diagnostic technologies and encourages innovation.
  • The automated immunoassay system for the VIDAS line, called VIDAS® KUBETM, received a new CE certification from bioMerieux. This will help the food industry and healthcare laboratories quickly service their customers.
Bacterial Disease Diagnostics Market
Market Opportunities and Challenges

  • Opportunities: Increasing Government Initiatives to Improve Healthcare - The World Health Organisation launched the programme Global Health and Peaces in 2021 to address the majority of disease outbreaks and the most pressing health needs of people. The government's goals for preventative healthcare are aligned with the importance of bacterial illness diagnostics for early diagnosis and rapid management of infections.
  • Challenges: Lack of Skilled Personnel and Adequate Infrastructure - Advanced diagnostic technologies are not properly supported by established infrastructure in many underdeveloped nations. Additionally, there aren't enough resources—both financial and human—to complete the process successfully.
Bacterial Disease Diagnostics Market


Market Competitive Landscape
The market exhibits a moderate level of fragmentation, with several major players, including Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc., Others. To strengthen their position in the market for infectious disease diagnostics, vendors are employing a variety of techniques, including strategic alliances, collaborations, mergers and acquisitions, geographic growth, and the development of new products and services.

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy Type, By Product, By Technology, By End User
 Regions coveredNorth America, Asia-Pacific, Latin America, Middle East & Africa and Europe
 Companies CoveredAbbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc., Others
COVID-19 Impact on Global Bacterial Disease Diagnostics Market
The new coronavirus that causes COVID-19 has spurred support from governments around the world for laboratories to expedite testing procedures. Although the pandemic reduced sales across many industries, its application in COVID-19 testing helped the market for infectious illness diagnostics. Regulatory authorities hastened COVID-19 diagnostic products' approval. Major corporations saw the crucial importance of diagnostics and quickly developed tests to reduce the pandemic's consequences. Despite a drop in worldwide instances, the COVID-19 spread has halted, which has resulted in a slower growth rate for the infectious disease diagnostics industry.

Key Target Audience
  • Clinical Laboratories
  • Environmental and Water Quality Testing Labs
  • Food and Beverage Industry
  • Health Insurance Providers
  • Hospitals and Healthcare Facilities
  • Medical Professionals
  • Patients and Caregivers
  • Pharmaceutical and Biotechnology Companies
  • Pharmacies and Pharmacist Practitioners
  • Public Health Agencies
  • Travel and Immigration Authorities
  • Veterinary Clinics and Animal Health Laboratories
  • Others
Our in-depth analysis of the Bacterial Disease Diagnostics Market includes the following segments:
By Type:
  • Bacterial Skin Infections
  • Foodborne Infections
  • Sexually Transmitted Infections
  • By Product:
  • Consumables
  • Instruments
  • By Technology:
  • DNA Microarray
  • Immunodiagnostics
  • Isothermal Nucleic Acid Amplification Technology
  • Polymerase Chain Reaction
  • By End User:
  • Hospitals
  • Labs
  • Research Centres
  • Key Topics Covered in the Report
    • Global Bacterial Disease Diagnostics Market Size (FY’2023-FY’2033)
    • Overview of Global Bacterial Disease Diagnostics Market
    • Segmentation of Global Bacterial Disease Diagnostics Market By Type (Bacterial Skin Infections, Foodborne Infections, Sexually Transmitted Infections)
    • Segmentation of Global Bacterial Disease Diagnostics Market By Product (Consumables, Instruments)
    • Segmentation of Global Bacterial Disease Diagnostics Market By Technology (DNA Microarray, Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction)
    • Segmentation of Global Bacterial Disease Diagnostics Market By End User (Hospitals, Labs, Research Centres)
    • Statistical Snap of Global Bacterial Disease Diagnostics Market
    • Expansion Analysis of Global Bacterial Disease Diagnostics Market
    • Problems and Obstacles in Global Bacterial Disease Diagnostics Market
    • Competitive Landscape in the Global Bacterial Disease Diagnostics Market
    • Impact of COVID-19 and Demonetization on Global Bacterial Disease Diagnostics Market
    • Details on Current Investment in Global Bacterial Disease Diagnostics Market
    • Competitive Analysis of Global Bacterial Disease Diagnostics Market
    • Prominent Players in the Global Bacterial Disease Diagnostics Market
    • SWOT Analysis of Global Bacterial Disease Diagnostics Market
    • Global Bacterial Disease Diagnostics Market Future Outlook and Projections (FY’2023-FY’2033)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Global Bacterial Disease Diagnostics Market

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Global Bacterial Disease Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bacterial Disease Diagnostics Market

    7. Global Bacterial Disease Diagnostics Market, By Type (USD Million)
    7.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Type, 2023-2033
    7.2. Bacterial Skin Infections
    7.3. Foodborne Infections
    7.4. Sexually Transmitted Infections

    8. Global Bacterial Disease Diagnostics Market, By Product (USD Million)
    8.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Product, 2023-2033
    8.2. Consumables
    8.3. Instruments

    9. Global Bacterial Disease Diagnostics Market, By Technology (USD Million)
    9.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Technology, 2023-2033
    9.2. DNA Microarray
    9.3. Immunodiagnostics
    9.4. Isothermal Nucleic Acid Amplification Technology
    9.5. Polymerase Chain Reaction

    10. Global Bacterial Disease Diagnostics Market, By End User (USD Million)
    10.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By End User, 2023-2033
    10.2. Hospitals
    10.3. Labs
    10.4. Research Centres

    11. Global Bacterial Disease Diagnostics Market Forecast, 2019-2033 (USD Million)
    11.1. Global Bacterial Disease Diagnostics Market Size and Market Share

    12. Global Bacterial Disease Diagnostics Market, By Type, 2019-2033 (USD Million)
    12.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2019-2026)
    12.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2027-2033)

    13. Global Bacterial Disease Diagnostics Market, By Product, 2019-2033 (USD Million)
    13.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2019-2026)
    13.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2027-2033)

    14. Global Bacterial Disease Diagnostics Market, By Technology, 2019-2033 (USD Million)
    14.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2019-2026)
    14.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2027-2033)

    15. Global Bacterial Disease Diagnostics Market, By End User, 2019-2033 (USD Million)
    15.1. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2019-2026)
    15.2. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2027-2033)

    16. Global Bacterial Disease Diagnostics Market, By Region, 2019-2033 (USD Million)
    16.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2019-2026)
    16.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2027-2033)
    16.3. Asia-Pacific
    16.3.1. Australia
    16.3.2. China
    16.3.3. India
    16.3.4. Japan
    16.3.5. South Korea
    16.3.6. Rest of Asia-Pacific
    16.4. Europe
    16.4.1. France
    16.4.2. Germany
    16.4.3. Italy
    16.4.4. Spain
    16.4.5. United Kingdom
    16.4.6. Rest of Europe
    16.5. Middle East and Africa
    16.5.1. Kingdom of Saudi Arabia 
    16.5.2. United Arab Emirates
    16.5.3. Rest of Middle East & Africa
    16.6. North America
    16.6.1. Canada
    16.6.2. Mexico
    16.6.3. United States
    16.7. Latin America
    16.7.1. Argentina
    16.7.2. Brazil
    16.7.3. Rest of Latin America

    17. Company Profile
    17.1. Abbott Laboratories
    17.1.1. Company details
    17.1.2. Financial outlook
    17.1.3. Product summary 
    17.1.4. Recent developments
    17.2. Accelerate Diagnostics Inc.
    17.2.1. Company details
    17.2.2. Financial outlook
    17.2.3. Product summary 
    17.2.4. Recent developments
    17.3. Becton Dickinson and Co.
    17.3.1. Company details
    17.3.2. Financial outlook
    17.3.3. Product summary 
    17.3.4. Recent developments
    17.4. Bio Rad Laboratories Inc.
    17.4.1. Company details
    17.4.2. Financial outlook
    17.4.3. Product summary 
    17.4.4. Recent developments
    17.5. bioMerieux SA
    17.5.1. Company details
    17.5.2. Financial outlook
    17.5.3. Product summary 
    17.5.4. Recent developments
    17.6. Bruker Corp.
    17.6.1. Company details
    17.6.2. Financial outlook
    17.6.3. Product summary 
    17.6.4. Recent developments
    17.7. Danaher Corp
    17.7.1. Company details
    17.7.2. Financial outlook
    17.7.3. Product summary 
    17.7.4. Recent developments
    17.8. DiaSorin SpA
    17.8.1. Company details
    17.8.2. Financial outlook
    17.8.3. Product summary 
    17.8.4. Recent developments
    17.9. EKF Diagnostics Holdings Plc
    17.9.1. Company details
    17.9.2. Financial outlook
    17.9.3. Product summary 
    17.9.4. Recent developments
    17.10. F. Hoffmann La Roche Ltd.
    17.10.1. Company details
    17.10.2. Financial outlook
    17.10.3. Product summary 
    17.10.4. Recent developments
    17.11. GENERI BIOTECH s.r.o.
    17.11.1. Company details
    17.11.2. Financial outlook
    17.11.3. Product summary 
    17.11.4. Recent developments
    17.12. Great Basin Scientific
    17.12.1. Company details
    17.12.2. Financial outlook
    17.12.3. Product summary 
    17.12.4. Recent developments
    17.13. Hologic Inc.
    17.13.1. Company details
    17.13.2. Financial outlook
    17.13.3. Product summary 
    17.13.4. Recent developments
    17.14. Meridian Bioscience Inc.
    17.14.1. Company details
    17.14.2. Financial outlook
    17.14.3. Product summary 
    17.14.4. Recent developments
    17.15. Perkin Elmer Inc.
    17.15.1. Company details
    17.15.2. Financial outlook
    17.15.3. Product summary 
    17.15.4. Recent developments
    17.16. QIAGEN NV
    17.16.1. Company details
    17.16.2. Financial outlook
    17.16.3. Product summary 
    17.16.4. Recent developments
    17.17. Quest Diagnostics Inc.
    17.17.1. Company details
    17.17.2. Financial outlook
    17.17.3. Product summary 
    17.17.4. Recent developments
    17.18. Siemens AG
    17.18.1. Company details
    17.18.2. Financial outlook
    17.18.3. Product summary 
    17.18.4. Recent developments
    17.19. T2 Biosystems Inc.
    17.19.1. Company details
    17.19.2. Financial outlook
    17.19.3. Product summary 
    17.19.4. Recent developments
    17.20. Takara Bio Inc.
    17.20.1. Company details
    17.20.2. Financial outlook
    17.20.3. Product summary 
    17.20.4. Recent developments
    17.21. Others
     
    18. List of Abbreviations

    19. Reference Links

    20. Conclusion

    21. Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Bacterial Disease Diagnostics Market grew in market size from 2022. The Market is expected to reach USD XX billion by 2033, at a CAGR of 6.5% during the forecast period.
    Bacterial Disease Diagnostics Market CAGR of 6.5% during the forecast period.
    Bacterial Disease Diagnostics Market size is USD XX billion from 2023 to 2033.
    Bacterial Disease Diagnostics Market Segment is covered By Type, By Product, By Technology, By End User.
    The North America is anticipated to have the highest market share in the Bacterial Disease Diagnostics Market .
    The key players in the market include Companies Covered Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA.
    The term "pathogen" refers to any bacterium that causes an infectious disease. To avoid overusing antibiotics and to target the right therapy, a precise identification of bacterial infection is essential.
    Bacterial Disease Diagnostics Market is projected to reach USD XX billion by 2033, growing at a CAGR of 6.5% during the forecast period.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here
    PLACE AN ORDER
    • 15% off
       
      $ 4250
    • 20% off
               
      $ 5650
    • 25% off
           
      $ 7450
    Pre-Purchase Inquiry
    SEND AN INQUIRY
    NEED CUSTOMIZATION?
    Request Customization
    CALL OR EMAIL US
    US:
    India:
    Email:
    100% Secure Payment

    SPER American Express
    SPER VISA
    SPER Master Card
    SPER Mestro
    SPER Paypal
    SPER CCAvenues

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-McKinsey
    SPER-Bain
    SPER-Max-Healthcare
    SPER-DHL
    SPER-SIEMENS
    SPER-IQVIA
    SPER-Pfizer
    SPER-LOREAL
    SPER-Kankar IMRB
    SPER-ITA
    SPER-PWC
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-IPSOS
    SPER-Heineken

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650